Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Padoan

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Clinical and Experimental Rheumatology|July 27, 2022
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitisCaterina Vacchi, Sofia Testoni, Marcella Visentini, et al.
Reumatismo|April 10, 2026
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseasesNicola Ughi, Roberto Padoan, Giovanni Adami, et al.
Allergy|October 31, 2023
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study groupMarco Caminati, Angelo Fassio, Federico Alberici, et al.
Annals of the Rheumatic Diseases|July 19, 2022
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational studyAlessandra Bettiol, Maria Letizia Urban, Federica Bello, et al.
Frontiers in Immunology|May 9, 2024
Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature reviewElisa Chapuis, Elodie Bousquet, Jean-François Viallard, et al.
Rheumatology (Oxford, England)|June 10, 2022
Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative studyJérome Hadjadj, Alice Canzian, Omer Karadag, et al.
Clinical and Experimental Rheumatology|October 6, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for RheumatologyAndreina Manfredi, Giulia Cassone, Raffaella Izzo, et al.
Rheumatology (Oxford, England)|February 24, 2026
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicenter observational studyGabriele Domenico Gallina, Marco Lanzillotta, Sara Maggioni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyOmer Karadag, Ertugrul Cagri Bolek, Gizem Ayan, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Clinical and Experimental Rheumatology|July 27, 2022
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitisCaterina Vacchi, Sofia Testoni, Marcella Visentini, et al.
Reumatismo|April 10, 2026
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseasesNicola Ughi, Roberto Padoan, Giovanni Adami, et al.
Allergy|October 31, 2023
Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: Report from the European EGPA study groupMarco Caminati, Angelo Fassio, Federico Alberici, et al.
Annals of the Rheumatic Diseases|July 19, 2022
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational studyAlessandra Bettiol, Maria Letizia Urban, Federica Bello, et al.
Frontiers in Immunology|May 9, 2024
Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature reviewElisa Chapuis, Elodie Bousquet, Jean-François Viallard, et al.
Rheumatology (Oxford, England)|June 10, 2022
Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative studyJérome Hadjadj, Alice Canzian, Omer Karadag, et al.
Clinical and Experimental Rheumatology|October 6, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for RheumatologyAndreina Manfredi, Giulia Cassone, Raffaella Izzo, et al.
Rheumatology (Oxford, England)|February 24, 2026
Clinical outcomes of subglottic stenosis in granulomatosis with polyangiitis: results of an international multicenter observational studyGabriele Domenico Gallina, Marco Lanzillotta, Sara Maggioni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyOmer Karadag, Ertugrul Cagri Bolek, Gizem Ayan, et al.
Pageof 8